Recro Pharma: 3Q Earnings Snapshot
MALVERN, Pa. (AP) _ Recro Pharma Inc. (REPH) on Friday reported a loss of $4.3 million in its third quarter.
On a per-share basis, the Malvern, Pennsylvania-based company said it had a loss of 19 cents.
The results did not meet Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 13 cents per share.
The specialty pharmaceutical company posted revenue of $25.3 million in the period, which beat Street forecasts. Three analysts surveyed by Zacks expected $19.8 million.
Recro Pharma expects full-year revenue in the range of $98 million to $100 million.
Recro Pharma shares have more than doubled since the beginning of the year. The stock has more than doubled in the last 12 months.